Your browser doesn't support javascript.
loading
Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities.
Abdel-Wahab, May; Coleman, C Norman; Eriksen, Jesper Grau; Lee, Peter; Kraus, Ryan; Harsdorf, Ekaterina; Lee, Becky; Dicker, Adam; Hahn, Ezra; Agarwal, Jai Prakash; Prasanna, Pataje G S; MacManus, Michael; Keall, Paul; Mayr, Nina A; Jereczek-Fossa, Barbara Alicja; Giammarile, Francesco; Kim, In Ah; Aggarwal, Ajay; Lewison, Grant; Lu, Jiade J; Guedes de Castro, Douglas; Kong, Feng-Ming Spring; Afifi, Haidy; Sharp, Hamish; Vanderpuye, Verna; Olasinde, Tajudeen; Atrash, Fadi; Goethals, Luc; Corn, Benjamin W.
Afiliación
  • Abdel-Wahab M; Division of Human Health, International Atomic Energy Agency, Vienna, Austria. Electronic address: m.abdel-wahab@iaea.org.
  • Coleman CN; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Eriksen JG; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
  • Lee P; Division of Human Health, International Atomic Energy Agency, Vienna, Austria.
  • Kraus R; Department of Radiation Oncology, Barrow Neurological Institute, Phoenix, AZ, USA.
  • Harsdorf E; Division of Human Health, International Atomic Energy Agency, Vienna, Austria.
  • Lee B; Department of Radiation Medicine, Loma Linda University, Loma Linda, CA, USA; Department of Radiation Oncology, Summa Health, Akron, OH, USA.
  • Dicker A; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Hahn E; Department of Radiation Oncology, Radiation Medicine Program, Princess Margaret Cancer Centre, University of Toronto, ON, Canada.
  • Agarwal JP; Department of Radiation Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Prasanna PGS; Radiation Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • MacManus M; Department of Radiation Oncology, Peter MacCallum Cancer Centre and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
  • Keall P; Image X Institute, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
  • Mayr NA; College of Human Medicine, Michigan State University, East Lansing, MI, USA.
  • Jereczek-Fossa BA; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Division of Radiotherapy, European Institute of Oncology, IRCCS, Milan, Italy.
  • Giammarile F; Division of Human Health, International Atomic Energy Agency, Vienna, Austria.
  • Kim IA; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul, South Korea; Seoul National University, College of Medicine, Seoul, South Korea.
  • Aggarwal A; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Lewison G; Institute of Cancer Policy, King's College London, London, UK.
  • Lu JJ; Shanghai Proton and Heavy Ion Centre, Fudan University School of Medicine, Shanghai, China.
  • Guedes de Castro D; Department of Radiation Oncology, Hcor and Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
  • Kong FS; Department of Clinical Oncology, HKU-Shenzhen Hospital and Queen Mary Hospital, Li Ka Shing Faculty of Medicine, Hong Kong Special Administrative Region, China.
  • Afifi H; Division of Human Health, International Atomic Energy Agency, Vienna, Austria.
  • Sharp H; Institute of Cancer Policy, King's College London, London, UK.
  • Vanderpuye V; National Center for Radiotherapy, Oncology and Nuclear Medicine, Korlebu Teaching Hospital, Accra, Ghana.
  • Olasinde T; Ahmedu Bello University Teaching Hospital, Zaria, Nigeria.
  • Atrash F; Augusta Victoria Hospital, Jerusalem, Israel.
  • Goethals L; Division of Human Health, International Atomic Energy Agency, Vienna, Austria.
  • Corn BW; Shaare Zedek Medical Center, Jerusalem, Israel.
Lancet Oncol ; 25(6): e270-e280, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38821101

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oncología por Radiación / Países en Desarrollo / Neoplasias Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oncología por Radiación / Países en Desarrollo / Neoplasias Límite: Humans Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2024 Tipo del documento: Article